We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman VU0134992
NETA PART: | CAYM-37299-10 |
MFG.PART: | 37299-10 |
UNSPSC: | 12352200 |
Manufacturer: | Cayman |
Product Description
An internal standard for the quantification of glycochenodeoxycholic acid (GCDCA; Item No. ) by GC- or LC-MS. GCDCA is a glycine-conjugated form of the primary bile acid chenodeoxycholic acid (Item No. ). It reduces formation of cholic acid (Item No. ) in primary human hepatocytes when used at a concentration of 100 µM. GCDCA (50, 75, and 100 µM) reduces the number of LC3 puncta, a marker of autophagy, and is cytotoxic to L-02 hepatocytes. GCDCA (50 µM) induces apoptosis in isolated rat hepatocytes, an effect that can be blocked by the protein kinase C (PKC) inhibitor chelerythrine (Item No. ). Fecal levels of GCDCA are decreased in a rat model of high-fat diet-induced obesity compared with rats fed a normal diet.
WARNING This product is not for human or veterinary use.
Technical Information
- GCDCA-d4
- DMF: 10 mg/ml
- DMSO: 10 mg/ml
- DMSO:PBS(pH 7.2) (1:4): 0.2 mg/ml
- Ethanol: 1 mg/ml
Shipping & Storage Information
SKU | CAYM-37299-10 |
---|---|
Supplier Part Number | 37299-10 |
UM | EA |
UNSPSC | 12352200 |
Manufacturer | Cayman |
Temperature | -20 |
Refrigerated-Frozen | Refrigerated |
ProductLine | CAYM |
Qty | 10 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 2 Business Days |